本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Karyopharm Therapeutics Inc.

1.61
-0.0100-0.62%
盤後1.60-0.0096-0.60%19:59 EDT
成交量:673.75萬
成交額:967.02萬
市值:3,648.73萬
市盈率:-0.12
高:1.61
開:1.50
低:1.24
收:1.62
52周最高:10.99
52周最低:1.24
股本:2,266.29萬
流通股本:1,577.42萬
量比:8.47
換手率:42.71%
股息:- -
股息率:- -
每股收益(TTM):-13.0816
每股收益(LYR):-17.9300
淨資產收益率:-891.05%
總資產收益率:-47.61%
市淨率:-0.11
市盈率(LYR):-0.09

資料載入中...

2021/06/24

重要事件披露

8-K - Current report
2021/05/24

重要事件披露

8-K - Current report
2021/05/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03

重要事件披露

8-K - Current report
2021/05/03

重要事件披露

8-K - Current report
2021/02/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

重要事件披露

8-K - Current report
2021/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2020/12/18

重要事件披露

8-K - Current report
2020/12/17

重要事件披露

8-K - Current report